The dopamine D1 receptor agonist and D2 receptor antagonist LEK-8829 attenuates reinstatement of cocaine-seeking in rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 369, Issue 6, 2004, Pages 576-582

  Milivojevič, Nataša ^a   Krisch, Igor ^b   Sket, Dušan ^a   Živin, Marko ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b Lek dd   (Slovenia)

Author keywords

Cocaine; Craving; Dopamine; Extinction; LEK 8829; Reinstatement; Self administration

Indexed keywords

9,10 DIDEHYDRO N METHYL N (2 PROPYNYL) 6 METHYL 8BETA AMINOMETHYLERGOLINE BIMALEATE; COCAINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; ERGOLINE DERIVATIVE; LEK 8829; UNCLASSIFIED DRUG; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DRUG DERIVATIVE; LYSERGIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SELF ADMINISTRATION; MALE; NONHUMAN; RAT; WITHDRAWAL SYNDROME; ADDICTION; ANIMAL; DISEASE MODEL; DRUG ANTAGONISM; DRUG POTENTIATION; PHYSIOLOGY; WISTAR RAT;

ANIMALS; BEHAVIOR, ADDICTIVE; COCAINE; COCAINE-RELATED DISORDERS; DISEASE MODELS, ANIMAL; LYSERGIC ACID; MALE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SELF ADMINISTRATION;

EID: 3042592435     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-004-0937-2     Document Type: Article

References (46)

1. Berger SP, Hall S, Mickalian JD, Reid MS, Crawford CA, Delucchi K, Carr K, Hall S (1996) Haloperidol antagonism of cue-elicited cocaine craving. Lancet 347:504-508
2. Bienkowski P, Koros E, Kostowski W, Bogucka-Bonikowska A (2000) Reinstatement of ethanol seeking in rats: behavioral analysis. Pharmacol Biochem Behav 66:123-128
3. Caine SB, Negus SS, Mello NK, Bergman J (1999) Effects of dopamine D1-like and D2-like agonists in rats that self-administer cocaine. J Pharmacol Exp Ther 291:353-360
4. Caine SB, Negus SS, Mello NK, Patel S, Bristow L, Kulagowski J, Vallone D, Saiardi A, Borrelli E (2002) Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists. J Neurosci 22:2977-2988
5. Callahan PM, Appel JB, Cunningham KA (1991) Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology (Berl) 103:50-55
6. Coffin VL, Latranyi MB, Chipkin RE (1989) Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors. J Pharmacol Exp Ther 249:769-774
7. De Lima MS, Oliveira Soares BG, Reisser AA, Farrell M (2002) Pharmacological treatment of cocaine dependence: a systematic review. Addiction 97:931-949
8. De Vries TJ, Schoffelmeer AN, Binnekade R, Vanderschuren LJ (1999) Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration. Psychopharmacology (Berl) 143:254-260
9. Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278
10. Everitt BJ, Dickinson A, Robbins TW (2001) The neuropsychological basis of addictive behaviour. Brain Res Brain Res Rev 36:129-138
11. Glavan G, Sket D, Zivin M (2002) Modulation of neuroleptic activity of 9,10-didehydro-N-methyl-(2-propynyl)-6-methyl-8-aminomethylergoline bimaleinate (LEK-8829) by D1 intrinsic activity in hemi-parkinsonian rats. Mol Pharmacol 61:360-368
12. Gottschalk PC, Jacobsen LK, Kosten TR (1999) Current concepts in pharmacotherapy of substance abuse. Curr Psychiatry Rep 1:172-178
13. Grech DM, Spealman RD, Bergman J (1996) Self-administration of D1 receptor agonists by squirrel monkeys. Psychopharmacology (Berl) 125:97-104
14. Haney M, Collins ED, Ward AS, Foltin RW, Fischman MW (1999) Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans. Psychopharmacology (Berl) 143:102-110
15. Jin GZ, Zhu ZT, Fu Y (2002) (-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions. Trends Pharmacol Sci 23:4-7
16. Khroyan TV, Barrett-Larimore RL, Rowlett JK, Spealman RD (2000) Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. J Pharmacol Exp Ther 294:680-687
17. Koob GF (2000) Neurobiology of addiction. Toward the development of new therapies. Ann NY Acad Sci 909:170-185
18. Kosten TR, George TP, Kosten TA (2002) The potential of dopamine agonists in drug addiction. Expert Opin Investig Drugs 11:491-499
19. Krisch I, Bole-Vunduk B, Pepelnak M, Lavric B, Ocvirk A, Budihna MV, Sket D (1994) Pharmacological studies with two new ergoline derivatives, the potential antipsychotics LEK-8829 and LEK-8841. J Pharmacol Exp Ther 271:343-352
20. Krisch I, Rucman R, Lavric A, Ocvirk M, Bole-Vunduk B (1996) A new ergoline derivative, LEK-8829, as a potential antipsychotic drug. CNS Drug Rev 2:294-307
21. Majewska MD (1996) Cocaine addiction as a neurological disorder: implications for treatment. NIDA Res Monogr 163:1-26
22. Matthews K, Robbins TW, Everitt BJ, Caine SB (1999) Repeated neonatal maternal separation alters intravenous cocaine self-administration in adult rats. Psychopharmacology (Berl) 141:123-134
23. McFarland K, Kalivas PW (2001) The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 21:8655-8663
24. Mierzejewski P, Koros E, Goldberg SR, Kostowski W, Stefanski R (2003) Intravenous self-administration of morphine and cocaine: a comparative study. Pol J Pharmacol 55:713-726
25. Parsons LH, Weiss F, Koob GF (1998) Serotonin1B receptor stimulation enhances cocaine reinforcement. J Neurosci 18:10078-10089
26. Peltier RL, Guerin GF, Dorairaj N, Goeders NE (2001) Effects of saline substitution on responding and plasma corticosterone in rats trained to self-administer different doses of cocaine. J Pharmacol Exp Ther 299:114-120
27. Platt DM, Rowlett JK, Spealman RD (2001) Modulation of cocaine and food self-administration by low- and high-efficacy D1 agonists in squirrel monkeys. Psychopharmacology (Berl) 157:208-216
28. Platt DM, Rowlett JK, Spealman RD (2002) Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development. Psychopharmacology (Berl) 163:265-282
29. Self DW (1998) Neural substrates of drug craving and relapse in drug addiction. Ann Med 30:379-389
30. Self DW, Nestler EJ (1998) Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Depend 51:49-60
31. Self DW, Stein L (1992) The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats. Brain Res 582:349-352
32. Self DW, Barnhart WJ, Lehman DA, Nestler EJ (1996) Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science 271:1586-1589
33. Self DW, Karanian DA, Spencer JJ (2000) Effects of the novel D1 dopamine receptor agonist ABT-431 on cocaine self-administration and reinstatement. Ann NY Acad Sci 909:133-144
34. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 168:3-20
35. Simpson DD, Joe GW, Fletcher BW, Hubbard RL, Anglin MD (1999) A national evaluation of treatment outcomes for cocaine dependence. Arch Gen Psychiatry 56:507-514
36. Sizemore GM, Gaspard TM, Kim SA, Walker LE, Vrana SL, Dworkin SI (1997) Dose-effect functions for cocaine self-administration: effects of schedule and dosing procedure. Pharmacol Biochem Behav 57:523-531
37. Skinner BF (1938) The behavior of organisms. Appleton-Century-Crofts, New York, pp 7, 65, 332
38. Sprah L, Zivin M, Sket D (1999) Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine. J Pharmacol Exp Ther 288:1093-1100
39. Weed MR, Woolverton WL (1995) The reinforcing effects of dopamine D1 receptor agonists in rhesus monkeys. J Pharmacol Exp Ther 275:1367-1374
40. Weiss F, Ciccocioppo R, Parsons LH, Katner S, Liu X, Zorrilla EP, Valdez GR, Ben Shahar O, Angeletti S, Richter RR (2001) Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann NY Acad Sci 937: 1-26
41. Weissenborn R, Whitelaw RB, Robbins TW, Everitt BJ (1998) Excitotoxic lesions of the mediodorsal thalamic nucleus attenuate intravenous cocaine self-administration. Psychopharmacology (Berl) 140:225-232
42. Wise RA (1984) Neural mechanisms of the reinforcing action of cocaine. NIDA Res Monogr 50:15-33
43. Withers NW, Pulvirenti L, Koob GF, Gillin JC (1995) Cocaine abuse and dependence. J Clin Psychopharmacol 15:63-78
44. Woolverton WL, Ranaldi R (2002) Comparison of the reinforcing efficacy of two dopamine D2-like receptor agonists in rhesus monkeys using a progressive-ratio schedule of reinforcement. Pharmacol Biochem Behav 72:803-809
45. Zivin M, Sprah L, Sket D (1996) The D1 receptor-mediated effects of the ergoline derivative LEK-8829 in rats with unilateral 6-hydroxydopamine lesions. Br J Pharmacol 119:1187-1196
46. Zivin M, Sprah L, Sket D (1998) Antiparkinsonian potential of interaction of LEK-8829 with bromocriptine. Eur J Pharmacol 349:151-157